Enhancing oncodermatology support: assessing patient utilization and satisfaction with educational resources for managing dermatologic toxicities of cancer treatment
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-025-04262-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Sabrina Saeed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, New Haven, CT, USA. sabrina.saeed@yale.edu. Hauptthemen laut MEDLINE: Patient Satisfaction, Neoplasms, Patient Education as Topic, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yale School of Medicine, New Haven, CT, USA. sabrina.saeed@yale.edu.
- Yale School of Medicine, New Haven, CT, USA.
- Department of Dermatology, Yale School of Medicine, New Haven, CT, USA. jonathan.leventhal@yale.edu.
Zitieren
APA
Saeed, S., Chen, T. X., Huggins, L., & Leventhal, J. (2025). Enhancing oncodermatology support: assessing patient utilization and satisfaction with educational resources for managing dermatologic toxicities of cancer treatment. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04262-3
Vancouver
Saeed S, Chen TX, Huggins L, Leventhal J. Enhancing oncodermatology support: assessing patient utilization and satisfaction with educational resources for managing dermatologic toxicities of cancer treatment. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04262-3
BibTeX
@article{Saeed2025,
author = {Saeed, Sabrina and Chen, Tiffany X and Huggins, Lenique and Leventhal, Jonathan},
title = {Enhancing oncodermatology support: assessing patient utilization and satisfaction with educational resources for managing dermatologic toxicities of cancer treatment},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-025-04262-3}
}
EUVIMED